[ad_1]
HONG KONG (Reuters) – China's food and drug regulator said on Tuesday it will be a full review of the production and sales process in a vaccine maker accused of falsifying data.
Boxes of Vials Containing Rabies Vaccines Manufactured by the Vaccine Maker Changsheng Biotechnology, is seen at a local disease prevention and control center in Huangshan, Anhui Province, China July 23, 2018. REUTERS / Stringer
State Food and Drug Changsheng Bio-technology Co Ltd's vaccine production and sales, it said in a statement posted on its website.
The regulator will also conduct a production review of every vaccine maker in the country to contain potential risks, the statement said.
China's drug regulator has accused Changsheng of manufacturing production and inspection records regarding rabies vaccine regularly given to infants.
Reporting by Meg Shen; Editing by Matthew Bigg Mpoke
Source link
